Skip to main content
Premium Trial:

Request an Annual Quote

LifeCodexx, Elucigene Diagnostics Partner to Offer NIPT in UK and Ireland

NEW YORK (GenomeWeb) – LifeCodexx and Elucigene Diagnostics said today that they have partnered to make LifeCodexx's noninvasive prenatal screening test, PrenaTest, available to patients in the UK and Ireland.

Konstanz, Germany based-LifeCodexx launched PrenaTest based on technology it licensed from Sequenom in 2012 and has made the test available throughout Europe. Elucigene Diagnostics, based in Manchester, UK, is a developer and distributor of prenatal and human genetic diagnostics.

Mark Street-Docherty, commercial manager of Elucigene Diagnostics, said in a statement that offering LifeCodexx's PrenaTest "complements our continued support for prenatal testing accuracy."

PrenaTest is now available in more than 40 countries throughout Europe and the Middle East, Michael Lutz, CEO of LifeCodexx, noted in a statement.

Earlier this year, LifeCodexx inked deals with partner labs in Germany and Switzerland for the test.

The Scan

Polarized Science Confidence

A new survey finds that confidence in science among US adults is increasingly polarized, the Associated Press says.

Time to Sit Back and Relax

NPR reports that the US National Institutes of Health has transferred the last of its eligible former research chimpanzees to a sanctuary.

Omicron-Focused Vaccines

The New York Times reports both Pfizer-BioNTech and Moderna have launched trials of SARS-CoV-2 vaccines targeting the Omicron variant.

Nature Papers Present Cloud-Computing Analysis Approach, Transcription Factor With Role in Bacterial Genome Organization

In Nature this week: researchers describe the free, open-source cloud-computing infrastructure Serratus and more.